Reaction
Injection Site Ulcer reporting signals
As of the last recalculation, Injection Site Ulcer appears in 931 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is INTERFERON BETA-1B (PRR 106.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Interferon Beta-1B | 83 | 106.2 | 106.6 |
| Buprenorphine | 87 | 23.1 | 23.1 |
| Nevirapine | 6 | 15.0 | 15.0 |
| Glatiramer Acetate | 37 | 14.4 | 14.4 |
| Interferon Beta-1A | 83 | 10.4 | 10.5 |
| Asfotase Alfa | 4 | 9.0 | 9.0 |
| Peginterferon Beta-1A | 5 | 8.6 | 8.6 |
| Inclisiran | 3 | 8.4 | 8.4 |
| Paliperidone Palmitate | 11 | 7.7 | 7.7 |
| Leuprolide Acetate | 25 | 7.4 | 7.4 |